No association between IRF3 polymorphism and susceptibility to hepatitis B virus infection in Chinese patients.

Authors:
Address: Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, Anhui Province, China.
Journal:


Publication:

abstract

AIM:

To investigate the association between three tag single nucleotide polymorphisms (tagSNPs) in interferon regulatory factors (IRF3) and the genetic susceptibility to chronic hepatitis B virus (HBV) infection.

METHODS:

We performed a case-control study of 985 Chinese cases of chronic HBV infection and 294 self-limiting HBV-infected individuals as controls. Three tagSNPs in IRF3 (rs10415576, rs2304204, rs2304206) were genotyped with the Multiplex SNaPshot technique. The genotype and allele frequencies were calculated and analyzed.

RESULTS:

The three SNPs showed no significant genotype/allele associations with chronic HBV infection. Overall allele P values were: rs10415576, P = 0.0908, odds ratio (OR) [95% confidence interval (CI)] = 1.1798 (0.9740-1.4291); rs2304204, P = 0.5959, OR (95% CI) = 1.0597 (0.8552-1.3133); rs2304206, P = 0.8372, OR (95% CI) = 1.0250 (0.8097-1.2976). Overall genotype P values were: rs10415576, P = 0.2106; rs2304204, P = 0.8458; rs2304206, P = 0.8315. There were no statistically significant differences between patients with chronic HBV infection and controls. Haplotypes generated by these three SNPs were also not significantly different between the two groups.

CONCLUSION:

The three tagSNPs of IRF3 are not associated with HBV infection in the Han Chinese population.



Related Articles
Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population.
J Viral Hepat. 2006
Association of TNF-alpha promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population.
Du T, Guo XH, Zhu XL, Li JH, Lu LP, Gao JR, Gou CY, Li Z, Liu Y, Li H. J Viral Hepat. 2006 Sep; 13(9):618-24.
Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population.
Liver Int. 2011
Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population.
Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y, Pan Y, Zhang H, Jiang J, Niu J. Liver Int. 2011 Sep; 31(8):1118-26. Epub 2011 Mar 30.
Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population.
World J Gastroenterol. 2005
Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population.
Zhang PA, Wu JM, Li Y, Yang XS. World J Gastroenterol. 2005 Mar 21; 11(11):1594-8.
Lack of association between the GRP78 polymorphisms in the promoter and 3' UTR and susceptibility to chronic HBV infection in a Chinese Han population.
BMC Med Genet. 2010
Lack of association between the GRP78 polymorphisms in the promoter and 3' UTR and susceptibility to chronic HBV infection in a Chinese Han population.
Zhu X, Li DP, Fan WG, Lin MC, Wang JL, Lin SQ, Huang JQ, Kung HF. BMC Med Genet. 2010 Jun 2; 11:83. Epub 2010 Jun 2.
Analysis of HLA-DQB1 gene polymorphisms in asymptomatic HBV carriers and chronic hepatitis B patients in the Chinese Han population.
Int J Immunogenet. 2006
Analysis of HLA-DQB1 gene polymorphisms in asymptomatic HBV carriers and chronic hepatitis B patients in the Chinese Han population.
Xi-Lin Z, Te D, Jun-Hong L, Liang-Ping L, Xin-Hui G, Ji-Rong G, Chun-Yan G, Zhuo L, Ying L, Hui L. Int J Immunogenet. 2006 Aug; 33(4):249-54.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.